ArticleFrontiers in cardiovascular medicine2026
Comprehensive coronary computed tomography angiography assessment in high-altitude diabetic populations: integrating plaque characteristics, pericoronary inflammation, and coronary function.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary computed tomography angiography (CCTA) provides complementary anatomical, inflammatory, calcific, and functional biomarkers, but their interpretation under chronic high-altitude exposure remains uncertain. We characterized CCTA phenotypes according to altitude and type 2 diabetes and explored associations with major adverse cardiovascular events (MACE). Methods: This retrospective matched cohort with prospective outcome ascertainment included adults undergoing clinically indicated CCTA for suspected coronary artery disease. Participants were classified by high-altitude residence (≥2,500 m for ≥5 years) or low-altitude residence (<500 m) and by diabetes status, forming four groups. Propensity score matching was performed separately within diabetes strata using age, sex, body mass index, and hypertension, yielding 174 participants in 87 matched pairs. CCTA assessment included pericoronary adipose tissue (PCAT) attenuation, plaque characteristics, coronary artery calcium (CAC), coronary stenosis, and vessel-specific CT-derived fractional flow reserve (CT-FFR). Primary models evaluated altitude, diabetes, and their interaction with adjustment for age, sex, body mass index, and hypertension. Associations with MACE were explored using univariable Cox models among participants with follow-up. Results: In primary covariate-adjusted analyses, diabetes was associated with higher PCAT attenuation, CAC, total plaque volume, plaque burden, and maximum stenosis and with lower left anterior descending (LAD) CT-FFR (all q ≤ 0.018). Compared with the low-altitude Han group, the high-altitude Tibetan group had higher LAD and right coronary artery CT-FFR and lower CAC and plaque burden (all q ≤ 0.037). Among 13 interaction tests, only the altitude × diabetes interaction for LAD-PCAT remained significant after false discovery rate correction (-6.62 HU; 95% CI, -10.32 to -2.91; raw Conclusion: Diabetes was associated with a more adverse coronary CCTA phenotype, whereas the high-altitude Tibetan group showed lower CAC and plaque burden and higher vessel-specific CT-FFR than the low-altitude Han group. The association between diabetes and LAD-PCAT attenuation differed between these groups. These findings warrant validation in larger, ethnically comparable longitudinal cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.